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Transgenic mouseThe embryonic endoderm is a multipotent progenitor cell population that gives rise to the epithelia of the
digestive and respiratory tracts, the liver and the pancreas. Among the transcription factors that have been
shown to be important for endoderm development and gut morphogenesis is GATA4. Despite the important
role of GATA4 in endoderm development, its transcriptional regulation is not well understood. In this study,
we identiﬁed an intronic enhancer from the mouse Gata4 gene that directs expression to the deﬁnitive
endoderm in the early embryo. The activity of this enhancer is initially broad in all endodermal progenitors,
as demonstrated by fate mapping analysis using the Cre/loxP system, but becomes restricted to the dorsal
foregut and midgut, and associated organs such as dorsal pancreas and stomach. The function of the intronic
Gata4 enhancer is dependent upon a conserved Forkhead transcription factor-binding site, which is bound
by recombinant FoxA2 in vitro. These studies identify Gata4 as a direct transcriptional target of FoxA2 in
the hierarchy of the transcriptional regulatory network that controls the development of the deﬁnitive
endoderm.lecular yMedicinaRegenerativa
pain. Fax: +34 954 461 664.
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During gastrulation, the developing embryo undergoes a precise
morphogenetic program that leads to the establishment of the basic
body plan. Just before gastrulation, the amniote embryo consists of an
epithelial layer called the epiblast, which is covered by an extraem-
bryonic layer, known as the visceral endoderm (Lawson et al., 1986;
Tam and Loebel, 2007). During gastrulation, cells in the epiblast
undergo an epithelial-to-mesenchymal transition, and ingress
through the primitive streak (Lawson et al., 1991). Ingressing epiblast
cells form the mesoderm and endoderm while the embryonic sur-
face forms the ectoderm. The presumptive deﬁnitive endoderm,
which gives rise to endodermal organs, displaces the extraembryonic
visceral endoderm, which gives rise to extraembryonic structures
such as the yolk sac (Kadokawa et al., 1987; Weber et al., 1999). The
visceral endoderm shares the expression of many genes with the
deﬁnitive endoderm (Sherwood et al., 2007).
After gastrulation, a series of morphogenetic movements trans-
form the deﬁnitive endoderm into a primitive gut tube surrounded by
mesoderm. The anterior and posterior regions of the primitive tube
fold ventrally and the tube becomes regionalized along the dorsal–ventral and anterior–posterior axes into foregut, midgut, and hindgut.
These subregions are deﬁned by speciﬁc genetic programs controlled
by cell non-autonomous factors derived from nearby mesoderm and
ectodermal tissues and mediated by transcription factors that directly
regulate gene expression in different endoderm-derived organs. (Bort
et al., 2004; Grapin-Botton and Melton, 2000; Kumar et al., 2003;
Molotkov et al., 2005; Serls et al., 2005; Stainier, 2002; Tremblay and
Zaret, 2005;Wells andMelton, 2000). The ventral foregut gives rise to
the liver, ventral pancreas, and lungs, while dorsal foregut and
anterior regions of the midgut contribute to the dorsal pancreas,
stomach, esophagus, and duodenum. The midgut and hindgut form
the small and large intestines, respectively (Lawson et al., 1986).
Among the transcription factors that have been shown to be
crucial for endoderm development is FoxA2, a member of the
Forkhead family of transcription factors (Costa et al., 1989; Lai et al.,
1990). In the early embryo, FoxA2 is expressed in both visceral and
deﬁnitive endoderm, the node, the notochord, and the ﬂoorplate (Ang
et al., 1993; Monaghan et al., 1993; Ruiz i Altaba et al., 1993; Sasaki
and Hogan, 1993). Later in development, FoxA2 is also present in
endoderm-derived tissues, including liver, lung, stomach, pancreas,
small intestine, and colon (Besnard et al., 2004). Targeted disruption
of foxa2 leads to embryonic lethality, and foxa2-null embryos display
malformation of the node, notochord, and foregut endoderm (Ang
et al., 1993; Weinstein et al., 1994). Recent studies, using conditional
inactivation approaches, have revealed that FoxA2 is also required at
later stages of development in various endoderm-derived organs (Gao
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et al., 2004; Zhang et al., 2005). Mechanistically, FoxA2 functions as
a “pioneer factor” by displacing linker histones from compacted
chromatin and facilitating the binding of other transcription factors,
including the zinc ﬁnger transcription factor GATA4 (Gualdi et al.,
1996; Zaret, 1999, 2008; Zaret et al., 2008).
GATA4 belongs to a family of transcription factors involved in
the differentiation of the endoderm in several evolutionarily diverse
organisms (Rehorn et al., 1996; Reiter et al., 2001; Zhu et al., 1997).
Among the members of the GATA family, GATA4 is the ﬁrst to be
expressed in the visceral and deﬁnitive endoderm. GATA4 is also
expressed broadly in the mesoderm of the early mouse embryo
(Arceci et al., 1993; Molkentin, 2000). Homozygous inactivation of
Gata4 in mice leads to embryonic lethality, and Gata4-null embryos
display severe defects in the visceral endoderm, malformations in
the ventral foregut, and major disruptions in heart morphogenesis
(Kuo et al., 1997; Molkentin et al., 1997), establishing a crucial role
of this transcription factor in these cell lineages. More recently, con-
ditional inactivation, tetraploid complementation, and mosaic anal-
yses of Gata4mutant mouse embryos have also revealed its important
role in the differentiation of a variety of endodermal-derived tissues
(Battle et al., 2008; Bosse et al., 2006; Dusing et al., 2001; Jacobsen
et al., 2002; Watt et al., 2007). Similarly, morpholino knockdown
experiments demonstrated a requirement of GATA4 for the proper
formation of endodermal organs in the zebraﬁsh (Holtzinger and
Evans, 2005). In addition to its role in differentiation of endodermal
derivatives, GATA4 also appears to participate in endoderm speciﬁ-
cation in cooperation with FoxA2 (Bossard and Zaret, 1998; Cirillo
et al., 2002; Zaret, 1999). However, despite the importance of GATA4
in the development of the early endoderm, relatively little is known
about its transcriptional regulation in vivo.
In this study, we identiﬁed a transcriptional enhancer from the
mouse Gata4 gene, referred to as Gata4 G4, which is located in the
second intron of the mouse Gata4 gene. Importantly, this novel
intronic enhancer directs expression to the deﬁnitive endoderm from
early stages in mouse development. As development proceeds, the
activity of the Gata4 G4 enhancer becomes restricted to cells of the
dorsal foregut and midgut. The cells marked by the activity of this
novel Gata4 enhancer at early stages contribute to all endodermal
progenitors, as indicated by Cre-based lineage tracing experiments.
Reporter gene expression directed by the Gata4 G4 enhancer in
transgenic embryos in vivo matches the expression of transcripts for
the Forkhead transcription factor FoxA2, and we show the Gata4 G4
enhancer contains an essential conserved Forkhead binding site that
is efﬁciently bound by recombinant FoxA2 protein and is required for
enhancer activity in vivo. Thus, our studies identify Gata4 as a direct
transcriptional target of the Forkhead transcription factor FoxA2
in the early endoderm and establish a Gata4-expressing progenitor
population that contributes to the entire deﬁnitive endoderm.
Materials and methods
Bioinformatic analyses, cloning, and mutagenesis
Sequence comparisons were performed by using BLAST and VISTA
algorithms (Altschul et al., 1990; Mayor et al., 2000). The 1107-bp G4
fragment of the mouse Gata4 gene was generated by PCR frommouse
genomic DNA using the following primers: 5′-tctgcatggaaccaagcttc-
cag-3′ and 5′-ccctgctaactgcagtcatgg-3′. This fragmentwas then cloned
as a HindIII–PstI fragment into the HindIII–PstI sites of the transgenic
reporter plasmid Hsp68-lacZ (Kothary et al., 1989). The Forkhead site
mutant in Gata4 G4 was created by using primers with the following
plus strand sequence: 5′-attataatcacagactagtcgcagaagtctcaaag-3′. The
sequence of the mutant fragment was conﬁrmed by sequencing
on both strands. The Gata4 G4 fragment fused to the Gata4 minimal
promoter containing the mouse Gata4 sequences from−443 to +52,relative to the transcriptional start site, was cloned into a Cre ex-
pression plasmid containing the Cre cDNA and the SV40 splice and
poly A signal sequences to generate plasmid Gata4-G4Gp-Cre. The
GenBank Accession number for the sequence of Gata4 G4 endodermal
enhancer is HM212783.
Generation of transgenic mice
Transgenic lacZ reporter and Cre constructs were digested from
their parental plasmid backbones with SalI, gel puriﬁed, and
suspended in 5 mM Tris–HCl, 0.2 mM EDTA, pH 7.4, at a concentration
of 2 μg/ml for pronuclear injection as described previously (Hogan
et al., 1994). Injected embryos were implanted into pseudopregnant
FVB females, and embryos were collected at indicated times for F0
analysis or were allowed to develop to adulthood for the establish-
ment of stable transgenic lines. DNA was extracted from the yolk
sac of embryos or from tail biopsies as previously described (Dodou
et al., 2003). The presence of the Gata4-G4-lacZ and Gata4-G4Gp-Cre
transgenes was detected by Southern blot using speciﬁc probes for
each allele.
X-gal staining, immunohistochemistry, and in situ hybridization
β-galactosidase expression in lacZ transgenic embryos or tissues
was detected by X-gal staining, which was performed as described
previously (Dodou et al., 2003). For the analysis of the Gata4-G4Gp-
Cre line, transgenic male founders were crossed with female Rosa26R
lacZ reporter mice (Soriano, 1999) and embryos were collected at
different stages of development. Transverse and sagittal sections from
X-gal stained embryos and tissues were prepared and counterstained
with Neutral Fast Red as described previously (Anderson et al., 2004).
GATA4 immunohistochemistry was performed as previously de-
scribed (Rojas et al., 2009). Brieﬂy, dewaxed sections were boiled in
antigen retrieval and incubatedwith 3% H2O2 for 15 min prior to block
with 3% normal goat serum. Incubation with anti-GATA4 antibody
(1:300 dilution) was done overnight at 4 °C. Incubation with
biotinylated anti-goat antibody (Vector Laboratories) at a 1:300 dilu-
tion was done at room temperature for 1 h. Immunoperoxidase
staining was performed using the Vectastain Elite ABC kit (Vector
Laboratories) and developed using the peroxidase substrate DAB
(Vector Laboratories).
Whole mount in situ hybridization was performed as described
previously (Rojas et al., 2005). Following staining, embryos were
sectioned at a thickness of 7 μm and counterstained with Neutral Fast
Red for visualization of embryonic structures. foxa2 antisense probe
was generated from pBluescript-FoxA2 containing the full-length
cDNA linearized with BamHI, and transcribed using T3 polymerase.
Electrophoretic mobility shift assay (EMSA)
DNA binding reactions were performed as described previously
(Dodou et al., 2003). The foxa2 cDNA was transcribed and translated
using the TNT Coupled Transcription-Translation System (Promega),
as described in the manufacturer's directions. FoxA2 protein was
generated from pcDNA1-FoxA2 plasmid using T7 polymerase. The
sense strand sequence of the mouse Gata4 G4 Forkhead site used
for EMSAwas: Fox 5′-gggggttaattataatcacaaataaacgcagaagtctcaaag-3′.
The sense strand sequences for the Forkhead mutant site was the
same as for the mutagenic primers described above.
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed using the ChIP assay kit from Upstate
Pharmaceuticals following the recommendations of themanufacturer.
Brieﬂy, a 10 cm plate containing approximately 1×106 AR42J rat cells
(Rosewicz et al., 1992), grown in Dulbecco modiﬁed Eagle medium
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treated with 1% paraformaldehyde at 37 °C for 10 min to crosslink
protein-DNA complexes. Cells were then lysed and sonicated to shear
the DNA into fragments approximately 500 bp in size. The cleared
supernatant was divided into two samples. One of the samples was
incubated with 4 μg of anti-FoxA2 antibody (Santa Cruz Biotechnol-
ogy) and the other sample was incubated with 4 μg of anti-rabbit IgG
(Santa Cruz Biotechnology) as a nonspeciﬁc control overnight at 4 °C.
The DNA fragments were then precipitated after incubating the lysate
and antibody mixture with protein A-agarose beads for 1 h. Reactions
were incubated in 200 mM NaCl at 65 °C for 4 h to reverse the
crosslinks, and DNA was recovered by phenol-chloroform extraction.
The following primers were used to amplify a fragment of 290 bp
encompassing the Gata4 G4 Forkhead site: 5′-cagttgaattgtcccaaatca-
gatc-3′ and 5′-ccaactgtggatgaacttagcttcc-3′.
Results
An intronic Gata4 endoderm-speciﬁc enhancer directs expression to the
dorsal foregut and midgut in mouse transgenic embryos
Comparison of the Gata4 sequences of mouse, human, and
opossum identiﬁed nine major regions of conserved non-coding
sequences, referred to as G1-G9 (Fig. 1). Previously, we demonstrated
that two of these conserved regions function as independent, modular
transcriptional enhancers: Gata4 G2 functions as a speciﬁc enhancer
in lateral mesoderm and a subset of its derivatives in the liver
mesenchyme and Gata4 G8 functions as a late-acting endoderm
enhancer (Rojas et al., 2005, 2009). The Gata4 G8 enhancer directs
expression to the foregut and midgut in transgenic mouse embryos,
beginning at embryonic day (E) 9.5 (Rojas et al., 2009), but this
enhancer is not active at earlier embryonic stages when endogenous
Gata4 transcripts are already robustly expressed (Molkentin, 2000;
Nemer and Nemer, 2003). Together, these observations suggested
that additional Gata4 endoderm enhancers must exist and prompted
us to test additional conserved sequences from the Gata4 locus for
enhancer activity in early transgenic embryos.
To identify additional Gata4 endoderm enhancers, we cloned each
conserved noncoding region from the Gata4 locus individually into
the transgenic reporter plasmid Hsp68-lacZ (Kothary et al., 1989) and
tested for enhancer activity in transgenic mouse embryos. These
analyses indeed resulted in the identiﬁcation of an additional
endoderm-speciﬁc enhancer element, which we refer to as Gata4
G4, with early activity in the visceral and deﬁnitive endoderm (Fig. 1).
The Gata4 G4 enhancer element encompasses a conserved region of
1107 bp, located between exons 2 and 3 (Fig. 1). To evaluate Gata4 G4
activity in vivo, we generated seven independent transgenic lines
harboring the Gata4-G4-lacZ transgene and analyzed them for β-
galactosidase reporter expression during embryonic development. Six
of the transgenic lines showed a consistent lacZ expression pattern in
all the embryonic stages analyzed.We ﬁrst observed enhancer activity
at E7.5 (Fig. 2A). At that stage, Gata4-G4-lacZ directed expression
to the visceral endoderm of the yolk sac, in agreement with theFig. 1. A schematic representation of the mouse Gata4 locus and the Gata4-G4-lacZ transg
transcriptional start site (bent arrow) is depicted in the top schematic. Conserved non-codin
red boxes (G1–G9). The lower schematic depicts the Gata4 G4 intronic sequences cloned inpreviously described early expression of endogenous Gata4 in the
extra-embryonic endoderm (Kuo et al., 1997; Molkentin et al., 1997;
Nemer and Nemer, 2003) (Fig. 2A). Extra-embryonic expression was
transient and no longer observed at any developmental stage after
E7.5 (Fig. 4A and data not shown). Later, at E8.5, robust Gata4-G4-lacZ
transgene expression was observed in the primitive gut tube formed
by the deﬁnitive endoderm (Fig. 2B–D). By E9.5, β-galactosidase
activity was observed in the ventral and dorsal part of the gut tube,
and became clearly restricted to the midgut (Fig. 2E, F, K). In the
foregut, X-gal staining was only observed in the most caudal/
posterior regions, indicating that enhancer activity did not extend
more rostrally than the developing liver (Fig. 2H). The expression of
the transgene was completely absent from the mesoderm component
of the gut, demonstrating the endodermal speciﬁcity of the Gata4 G4
element in vivo.
To characterize the Gata4 endoderm enhancer in more detail, we
compared the expression pattern directed by the enhancer with the
expression pattern of the endodermal transcription factor FoxA2 (Ang
et al., 1993). The expression patterns of the Gata4-G4-lacZ transgene
and foxa2 appeared to be nearly identical in the posterior foregut
and midgut (Fig. 2, compare panels E, F, H, K to panels G, I, L). The
expression of the Gata4-G4-lacZ transgene also partially overlapped
the expression of endogenous GATA4 protein in the posterior foregut
and midgut at E9.5 (Fig. 2 compare panels H, K to panels J, M). Thus,
these results indicate that G4 enhancer faithfully recapitulates Gata4
endogenous expression in the early endoderm in transgenic embryos.
Endogenous GATA4 protein expression was broader than Gata4-
G4-lacZ and included other derivatives of the endoderm and
mesoderm, such as the entire foregut and gut mesenchyme (Fig. 2J,
M), consistent with previously published reports (Arceci et al., 1993).
The broader expression of endogenous GATA4 protein relative to
Gata4-G4-lacZ was expected since endogenous GATA4 expression is
controlled by multiple independent enhancers with activity in the gut
(Rojas et al., 2005, 2009), and the Gata4 G4 enhancer controls only
a subset of the endogenous pattern of expression. In addition to its
expression in the developing gut endoderm, we also observed Gata4-
G4-lacZ expression in the ﬂoor plate (Fig. 2H, K) even though
endogenous GATA4 protein was not detectable in the ﬂoor plate by
immunohistochemistry (Fig. 2J, M). This discrepancy might reﬂect the
absence of additional regulatory sequences in the Gata4 G4 enhancer
that normally repress endogenous Gata4 expression in the ﬂoor plate.
Gata4 G4 enhancer activity is restricted to the epithelium of the
hind-stomach and dorsal pancreatic bud
At E11.5, expression directed by the Gata4 G4 enhancer was
observed only in a subset of endoderm-derived organs, the epithelium
of the glandular stomach, and the dorsal pancreatic bud (Fig. 3A–C).
By E13.5, transgene activity was restricted to the glandular (hind)
stomach, although at lower levels compared to earlier stages of de-
velopment and it was absent in the anterior stomach (Fig. 3D). These
results are in agreement with the previously described expression of
endogenous Gata4 in the developing stomach (Jacobsen et al., 2005).ene. The mouse Gata4 locus, including the seven Gata4 exons (vertical lines) and the
g regions among the human, mouse and opossum Gata4 sequences are represented as
to the reporter vector HSP68-lacZ.
Fig. 2. The Gata4-G4-lacZ transgene is expressed in the visceral and deﬁnitive endoderm, dorsal foregut, midgut, and derivatives of the deﬁnitive endoderm in the developing
stomach and pancreas during mouse embryonic development. Whole mount (A, B, E), sagittal (C, F) and transverse (D, H, K) sections of X-gal stained Gata4-G4-lacZ transgenic
embryos are shown. For comparison, whole mount (G) and transverse (I, L) sections of foxa2 in situ hybridization and transverse sections (J, M) of GATA4 immunohistochemistry are
shown. White arrowheads mark the deﬁnitive endoderm. Transgene expression was only detected transiently in the visceral endoderm of the yolk sac (ys) at E7.5 (A). At slightly
later stages, Gata4-G4-lacZ expression appeared in the deﬁnitive endoderm (B–D). By E9.5, lacZ expression became restricted to the caudal foregut (fg) and midgut (mg) where
expression mirrored the expression of the endodermal marker foxa2 (G, I, L) and endogenous GATA4 (J, M) but was absent in the anterior foregut (black arrows). Bars in all
panels=100 μm. h, heart; st, septum transversum.
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detectable β-galactosidase activity at E13.5 (Fig. 3E). No transgene
expression was observed in the mesenchyme surrounding the
stomach and pancreas, indicating the speciﬁcity of the G4 enhancer
to direct expression in the endodermal component of these organs. At
later stages in fetal development, the Gata4-G4-lacZ transgene was no
longer active since no β-galactosidase activity was observed in either
the hind stomach epithelium or the pancreas (Fig. 3F). The decreased
expression of the transgene coincides with terminal cell differentia-tion and maturation, suggesting that the Gata4 G4 enhancer is active
mainly at early stages of endoderm development.
Gata4-G4-Cre expressing cells and their descendents contribute to all
endodermally-derived organs
The results shown in Fig. 2 demonstrated that the Gata4-G4-lacZ
transgene was expressed very early in the deﬁnitive endoderm of the
mouse embryo but then became restricted to a subset of endoderm
Fig. 3. Expression directed by the Gata4-G4-lacZ transgene becomes restricted to the stomach epithelium and dorsal pancreatic bud. Whole mount (A) and sagittal sections (B–F) of
X-gal-stained Gata4-G4-lacZ transgenic embryos are shown. At E11.5, X-gal staining was observed in the nascent epithelium of the hind stomach and in the pancreatic epithelium
(A–C). By E13.5, transgene activity began to diminish in both the hind stomach (arrowhead in D) and the pancreas epithelium (pan epi) (E). No transgene expression was observed
at E16.5 (F). Arrow marks the anterior stomach and asterisk indicates the stomach mesenchyme in D. (sto) stomach; (eso) esophagus; (duo) duodenum; (pan) pancreas; (pan m)
pancreas mesenchyme (li), liver.
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enhancer in the endoderm suggested that the cells initially and
transiently marked by Gata4-G4-lacZ might contribute extensively to
organs derived from the deﬁnitive endoderm. Therefore, to investi-
gate the developmental potential of the progenitors marked by the
early activity of the Gata4 G4 enhancer, we generated transgenic mice
in which the expression of Cre recombinase was controlled by the
Gata4 G4 enhancer linked to the minimal promoter region of Gata4.
We crossed these mice, referred to as Gata4-G4Gp-Cre, to Rosa26R
lacZ reporter mice, which express β-galactosidase constitutively and
indelibly in a Cre-dependent manner (Soriano, 1999). We compared
the Cre-dependent lacZ expression in these embryos to the lacZ
expression directly under the control of the Gata4 G4 enhancer
at different stages of development. As mentioned above, Gata4 G4
enhancer activity in the yolk sac was transient, rapidly extinguishing
after E7.5 (Figs. 2A and 4A). However, in Gata4-G4Gp-CreTg/0;
Rosa26lacZ/+ embryos, β-galactosidase activity was observed in the
yolk sac at all stages of embryonic development (Fig. 4B. and data not
shown). These results indicate that the early activation of the Gata4
G4 enhancer in the visceral endoderm marks all of the progenitors
that will give rise to the extra-embryonic endoderm of the yolk sac. As
shown in Fig. 3, at E11.5, the Gata4-G4-lacZ transgene was clearly
active in the hind stomach and pancreatic epithelium (Figs. 3A–C and
4C, E). In Gata4-G4Gp-CreTg/0; Rosa26lacZ/+ embryos, β-galactosidase
activity was also observed in the stomach epithelium and pancreatic
bud, but its expression was broader than the expression of the Gata4-
G4-lacZ transgene and was present in the epithelium of other
endoderm derivatives, including the liver, and duodenum (Fig. 4D, F),
indicating that these structures are derived from a Gata4-G4-lacZ-
expressing progenitor population.
At E13.5, the Cre-dependent lacZ expression of the Gata4-G4Gp-
CreTg/0; Rosa26lacZ/+ embryos was detected throughout the endoder-
mal organs of the gastrointestinal and respiratory tract, including
fore- and hind stomach, esophagus, duodenum, branching epithelium
of the lung and in both dorsal and ventral pancreases (Fig. 4H, J). By
comparison, the direct activity of the Gata4G4 enhancer (as measured
by Gata4-G4-lacZ expression) was detectable only in a few cells of
the dorsal pancreas and hind stomach and was completely absentfrom other endodermal organs, including the lungs and the liver
(Fig. 4G, I, K). The β-galactosidase activity in Gata4-G4Gp-CreTg/0;
Rosa26lacZ/+ embryos remained robust at later stages of fetal de-
velopment and after birth in all endodermal organs, including the
liver and the lungs (Figs. 4L and 5F), indicating that the Gata4 G4-
marked progenitor population stably contributed the majority of cells
to all of the endodermal derivatives in the mouse. The speciﬁcity of
the Gata4 G4 enhancer for the endodermwas clearly evident based on
the complete absence of contribution of any Gata4-G4Gp-Cre-marked
cells in any organs of mesodermal origin, such as kidney, spleen, and
heart (Fig. 5B, D, F). Likewise, Cre activity was completely absent in
the mesenchymal compartment of the lung (Fig. 4J). Taken together,
these results show that the Gata4 G4 enhancer is expressed in a
progenitor cell population, which gives rise to the majority of cells in
endoderm-derived organs.
The Forkhead transcription factor FoxA2 binds to a conserved, consensus
Forkhead binding site in the Gata4 G4 endoderm enhancer
To identify how Gata4 expression is controlled in the early endo-
derm via the Gata4 G4 enhancer, we analyzed the Gata4 G4 element
for evolutionarily conserved sequences that might serve as potential
cis-regulatory elements. These analyses identiﬁed a consensus
binding site for Forkhead proteins (Fig. 6A). The presence of a perfect,
conserved potential binding site for Forkhead transcription factors,
combined with the overlapping expression patterns of Gata4-G4-lacZ
and foxa2 throughout development (Fig. 2), suggested a potential
direct regulatory relationship between FoxA2 and Gata4 via the Gata4
G4 enhancer through the conserved Forkhead site in the enhancer.
As an initial test of this hypothesis, we examined the ability of
recombinant FoxA2 protein to bind to the Forkhead site in the Gata4
G4 enhancer by Electrophoretic Mobility Shift Assay (EMSA) (Fig. 6B).
FoxA2 efﬁciently bound to the Gata4 G4 Fox site (Fig. 6B, lane 8).
Binding was speciﬁc because it was competed by excess unlabeled
control Forkhead site (Fig. 6B, lane 9) and by excess unlabeled Gata4
G4 Forkhead site (Fig. 6B, lane10), but not by excess unlabeledmutant
versions of either control or Gata4 G4 Forkhead site (Fig. 6B, lanes 11,
12). To examine the binding of FoxA2 to the Gata4 G4 enhancer in
Fig. 5. The Gata4 G4 enhancer is not active in the mesoderm or its derivatives at any
stage in development. Representative organs dissected from Gata4-G4-lacZ (A, C, E) and
Gata4-G4Gp-CreTg/0, Rosa26 lacZ/+ (B, D, F) newborn mice (P0) were assayed for ß-
galactosidase activity. Gata4-G4Gp-Cre indelibly labeled cells in the lung epithelium of
newborn mice (arrowhead in F), consistent with its activity in the endoderm. At that
stage, no direct expression of the Gata4-G4-lacZ transgene was observed in the lungs
(arrowhead E). No mesodermal organs, including kidney (k) (A, B), spleen (sp) (C, D),
or heart (asterisks in E, F) were labeled in either Gata4-G4-lacZ or Gata4-G4Gp-CreTg/0;
Rosa26RlacZ/+ mice.
351A. Rojas et al. / Developmental Biology 346 (2010) 346–355more detail, we determined the ability of the Gata4 G4 Forkhead site
and the mutant version of this site to compete for FoxA2 binding to a
bona ﬁde control Fox site. Binding of FoxA2 to the control site wasFig. 4. The Gata4 G4 enhancer is active in all endodermal progenitors in the mouse
embryo. Yolk sac (A, B), sagittal (C, D) and transverse (E, F) sections and dissected
organs (G-L) collected from either Gata4-G4-lacZ (A, C, E, G, I, K) orGata4-G4Gp-CreTg/0,
Rosa26 lacZ/+ (B, D, F, H, J, L) transgenic embryos were stained for ß-galactosidase
activity with X-gal. At E11.5, Gata4-G4-lacZ expression was absent in the yolk sac and
detected only in the epithelium of the hind stomach and pancreas (A, C, E). Gata4-
G4Gp-CreTg/0, Rosa26 lacZ/+ embryos exhibited a similar pattern of lacZ expression in
these tissues, but expression was also apparent in other endoderm-derived including
the yolk sac and organs, such as liver, duodenum(B, D, F), indicating that the Gata4 G4
enhancer was once active in the progenitors of these organs at earlier stages. By E13.5,
the activity of Gata4-G4-lacZ transgene activity became weaker and staining was only
observed in the dorsal pancreas and hind-stomach (E). No staining was observed in the
lungs of Gata4-G4-lacZ transgenic embryos (I) at E13.5 or in the liver at E16.5 (K). By
contrast, Gata4-G4Gp-CreTg/0, Rosa26 lacZ/+ embryos exhibited X-gal staining in both
dorsal and ventral pancreases, fore- and hind stomach, duodenum, esophagus, liver,
and lungs (H, J, L), indicating that these structures were derived from an earlier Gata4-
G4Gp-Cre-expressing population of cells. Note the speciﬁc X-gal staining of Gata4-
G4Gp-CreTg/0, Rosa26 lacZ/+ embryos in the endoderm compartment of the lung (en)
but not in the mesenchymal (m) component (J). (sto), stomach; (pan), pancreas; (dpan),
dorsal pancreas; (vpan), ventral pancreas; (h), heart; (nt), neural tube; (li), liver; (lu),
lungs; (duo), duodenum.
Fig. 6. The Gata4-G4-lacZ transgene contains an evolutionary conserved Forkhead
binding site that is bound by FoxA2 protein in vitro and in vivo. (A) ClustalW analysis of
Gata4 G4 sequences from mouse, human, and opossums revealed a highly conserved,
perfect consensus Forkhead binding site (orange box). Asterisks denote nucleotides
that have been perfectly conserved among the three species. (B) Recombinant FoxA2
protein was used in EMSA with radiolabeled double-stranded oligonucleotide probe
representing a canonical Forkhead binding site from the Gata4 G2 lateral mesoderm
enhancer (Rojas et al., 2005) (lanes 1–6) or the Gata4 G4 Forkhead site (lanes 7–12).
Lanes 1 and 7 contain reticulocyte lysate without recombinant FoxA2 protein. FoxA2
efﬁciently bound to the Forkhead control site and to the Gata4 G4 Forkhead site (lanes
2, 8). In both cases, binding was competed by excess, unlabeled control Forkhead site
(C, lanes 3 and 9) or unlabeled Gata4 G4 Forkhead site (G4, lanes 4 and 10), but not by
excess unlabeled mutant control (mC, lanes 5 and 11) or an unlabeled mutant version
of the Gata4 G4 (M, lanes 6 and 12) Forkhead sites. (C) FoxA2 binds to the endogenous
Gata4 G4 enhancer in vivo. AR42J pancreatic cells were subjected to ChIP to detect
endogenous FoxA2 bound to the Gata4 G4 enhancer using anti-FoxA2 antibody.
Following ChIP, the Gata4 G4 Forkhead site was detected using speciﬁc primers ﬂanking
the Gata4 G4 Fox binding site. PCR products were analyzed by agarose gel
electrophoresis. Lane 2 contains PCR product obtained following ChIP using anti-
FoxA2 antibody (α-Fox). Lane 3 contains PCR product obtained following ChIP using a
non-speciﬁc anti-IgG (α-IgG). Lane 1 contains PCR product from input (Inp) ampliﬁed
prior to immunoprecipitation. Sizes in bp are shown at the left.
Fig. 7. The Gata4 G4 early endoderm enhancer is dependent on its conserved Forkhead
(Fox) site for activity in vivo. Wild type and mutant versions of the Gata4-G4-lacZ
transgene were used to generate transgenic embryos. Lateral (A, B) and frontal view
(C, D) of X-gal stained transgenic embryos at E8.5 are shown. The wild type construct
reproducibly directed expression to the deﬁnitive endoderm (A, C). Mutation of the
Gata4 G4 Forkhead site completely abolished transgene expression in each of three
independently-generated F0 transgenic embryos analyzed (B, D). Arrowheads mark the
deﬁnitive endoderm in all four panels.
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not affected by the addition of an excess of mutant version of the
Gata4 G4 Forkhead site (Fig. 6B, lanes 4, 6).
To investigate whether the Gata4 G4 Forkhead site is occupied
by FoxA2 in cells of endodermal origin, we performed chromatin
immunoprecipitation (ChIP) assays in cells of the AR42J pancreatic
cell line (Fig. 6C). The AR42J cell line was derived from a chemically-
induced rat exocrine pancreatic tumor and expresses numerous
endodermal pancreatic transcription factors, including GATA4 and
FoxA2 (Aldibbiat et al., 2008; Decker et al., 2006; Rosewicz et al.,
1992). Importantly, the DNA fragment encompassing the Forkhead
site in the endogenous Gata4 G4 enhancer was precipitated and
ampliﬁed by PCR when anti-FoxA2 antibody was added to the re-
action but not when non-speciﬁc IgG was used for ChIP (Fig. 6C).These results demonstrate that endogenous FoxA2 binds to the
Forkhead site in the endogenous Gata4 G4 enhancer in its normal
chromatin context in endodermally-derived cells. Taken together
with the results of the EMSA shown in Fig. 6B, these results establish
the Forkhead site in the Gata4 G4 enhancer as a FoxA2 binding site,
supporting the notion that Gata4 is a direct transcriptional target of
FoxA2 via the Gata4 G4 enhancer. Direct regulation of Gata4 by FoxA2
would be consistent with the overlapping expression of Gata4-G4-
lacZ and foxa2 (Fig. 2).Gata4 G4 endoderm enhancer activity is dependent on Forkhead-binding
site in vivo
To determine the requirement for Forkhead transcription factor
binding to the Gata4 G4 enhancer for function in vivo, we introduced
mutations identical to those used in EMSA to completely abolish
FoxA2 binding to the site in vitro (Fig. 6B). We then generated
transgenic mice harboring the Gata4-G4-lacZ mutant version and
determined the effect of the Fox site mutation on enhancer activity
compared to the wild type Gata4-G4-lacZ construct at E8.5 (Fig. 7).
As in the results shown in Fig. 2, robust expression of the wild type
Gata4-G4-lacZ transgene was observed in the deﬁnitive endoderm
(Fig. 7A, C). In sharp contrast, mutation of the Forkhead binding site
in the Gata4 G4 enhancer completely eliminated transgene
expression in all three independently generated transgenic lines
examined (Fig. 7B, D), indicating a critical role for Forkhead
transcription factor binding, likely FoxA2, in the activation of the
enhancer. Taken together, the coexpression data showing near
precise overlap of the expression of foxa2 andGata4-G4-lacZ (Fig. 2),
the strong binding of FoxA2 protein to the perfect consensus
Forkhead site in the enhancer (Fig. 6), and the absolute requirement
of the Fox site for enhancer function in vivo, strongly support a
pathway in which FoxA2 is a direct transcriptional activator of Gata4
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these studies.
Discussion
Dynamic expression and modular regulation of Gata4 during endoderm
development
The Gata4 G4 enhancer described here directs robust expression to
the endoderm in the early developing mouse embryo. The activity
of this enhancer becomes restricted at midgestation to a small subset
of endodermal derivatives in the dorsal foregut and midgut that will
form the dorsal pancreas and stomach. Our Cre-based fate mapping
experiments show that the total temporal and spatial activity of the
Gata4 G4 enhancer from its initial activation broadly in the endo-
derm at early times to its more restricted activity later results in the
marking of all deﬁnitive endodermal derivatives from both ventral
and dorsal foregut, midgut, and hindgut. When this broad contribu-
tion of Cre-marked cells is compared to the very restricted expression
of the Gata4-G4-lacZ transgene at later stages of development, the
results suggest that that the Gata4-G4 positive cells represent a pool of
early multipotent endodermal progenitors, and while the activity of
the enhancer itself is extinguished, the cells marked by the enhancer
at early stages ultimately contribute to essentially all endodermally-
derived cells in the embryo. However, we cannot formally exclude
a very transient expression of the Gata4-G4 enhancer in other gut
domains at later stages that may account for the further contribution
of Gata4-G4 positive cells to all endodermal derivatives.
We have recently described another Gata4 endoderm enhancer,
referred to as Gata4 G8 (Rojas et al., 2009). Interestingly, the Gata4
G8 enhancer directs expression to the visceral and deﬁnitive endo-
derm at later stages of development than the Gata4 G4 enhancer
described in the present studies. The previously described Gata4 G8
enhancer is active in the primitive gut tube and yolk sac beginning
at E9.5. In contrast to the Gata4 G4 enhancer described here, the
previously described Gata4 G8 enhancer remains active at later stages
of development, although its activity also becomes restricted to
pancreas, stomach and duodenum and yolk sac (Rojas et al., 2009).
The existence of two endoderm-speciﬁc enhancers in the Gata4 gene
might be related to the multiple roles of this transcription factor in
endoderm development and, more speciﬁcally, in the development of
pancreas and stomach. Alternatively, the two enhancersmight represent
temporally discrete transcriptional units with the early Gata4 G4
enhancer serving as an initiation element and the later Gata4 G8
enhancer serving as a maintenance unit. This type of model would be
consistent with previously described examples of transcriptional control
in the endoderm and other lineages where multiple enhancers
differentially regulate initial activation versus maintenance of gene
expression (ChenandGoldhamer, 2004;Meredith et al., 2009; Sasaki and
Hogan, 1996; Teboul et al., 2002). It is interesting that the activities of
Gata4 G4 and Gata4 G8 enhancers overlap at E9.5 in the dorsal foregut
and midgut, a key period in endoderm development when organ buds
start to form. The selective advantage of the modularity is not well
understood, but perhaps it serves to ﬁne tune the spatiotemporal and
quantitative control of Gata4 expression and the subsequent transcrip-
tional programs downstream of this key transcription factor gene.
The rapid and progressive restriction of the Gata4 G4 enhancer
activity from E7.5 to E11.5 suggests that the activators of the enhancer
might also become restricted during development. Alternatively,
the enhancer may contain speciﬁc sites for repressors that inhibit
enhancer activation in other tissues. One of the most intriguing
aspects of the expression pattern directed by the Gata4 G4 enhancer is
the exclusive localization to the caudal foregut and midgut region of
the gut tube at later times in its activity. It is well known that the
developing endoderm displays clear anterior–posterior patterning
inﬂuenced by signals from the adjacent germ layers that act in agraded manner (Kumar et al., 2003). These signals are critical for the
proper development of the gut tube. The speciﬁc expression pattern
directed by the Gata4 G4 enhancer suggests that it may respond to
different thresholds of mesodermal signals that restrict its activity in
the precise anterior–posterior pattern observed in the present studies.A transcriptional regulatory network for endoderm development by
GATA4 and FoxA2
GATA and Forkhead transcription factors are involved in the
speciﬁcation and differentiation of different endodermal cell types in
different organisms, including the ﬂy, the nematode, the mouse, and
the ﬁsh (Dufort et al., 1998; Fukushige et al., 1998; Mango et al., 1994;
Narita et al., 1997; Reiter et al., 2001; Weigel et al., 1989; Zhu et al.,
1997). GATA4 and FoxA2 are among the earliest transcription factors
to be expressed in the embryonic endoderm in the mouse, and they
synergistically activate the expression of endoderm-speciﬁc genes
(Cirillo et al., 2002; Denson et al., 2000). In this study, we demonstrate
that the Gata4 G4 endoderm enhancer requires a conserved Forkhead
binding site for function in vivo. Based on the overlapping expression
pattern of foxa2 and Gata4-G4-lacZ transgene and the efﬁcient binding
of FoxA2 to the Forkhead site in the Gata4 G4 enhancer in vitro and in
vivo (Figs. 2 and 6), our studies strongly support a role for FoxA2 as a
direct transcriptional regulator of Gata4 in the early endoderm.
It would be interesting to determine if the direct regulatory
relationship between GATA4 and FoxA2 is reciprocal, since it has
been shown in other organisms that GATA factors are likely direct
regulators of Forkhead genes. For example, the Drosophila GATA4
ortholog Serpent inﬂuences the expression of forkhead in the
midgut (Casanova, 1990; Reuter, 1994). Similarly, the promoter of
PHA-4, the C. elegans FoxA2 ortholog, is bound and transactivated by
two different GATA factors, ELT-1 and ELT-2, in the worm (Azzaria
et al., 1996; Horner et al., 1998; Kalb et al., 1998). The reciprocal
activation of Gata4 and FoxA2 could serve to reinforce in a feed-
forward fashion a regulatory circuit designated to amplify a
transcriptional response for speciﬁcation and differentiation of
different endodermal organs.
A mechanism by which FoxA2 and GATA4 might function together
in multipotent endoderm cells has been described previously. GATA4
and FoxA2 serve as pioneer factors for the induction of endoderm
gene expression, and they were shown to bind to the chromatin of
the silent Alb gene in the endoderm prior to the hepatic induction
(Bossard and Zaret, 1998; Cirillo et al., 1998; Zaret, 1999). Upon
inductive and permissive signals, the two transcription factors relax
the compacted chromatin, allowing the binding of other transcription
factors to activate the transcription of Alb and other genes to initiate
the liver program (Bossard and Zaret, 1998; Cirillo et al., 2002). Our
studies, described here, support a feed forward model for endoderm
speciﬁcation in which FoxA2 directly activates the expression of its
own transcriptional partner GATA4. It will be interesting to determine
whether this mechanism involving GATA4 and FoxA2 represents a
general mechanism by which endoderm competence is predeter-
mined. Genome-wide analyses of FoxA2 and GATA4 bound to their
targets in multipotent endodermal cells will provide new insights into
how cell speciﬁcation is achieved along the gut tube.Acknowledgments
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